Advertisement

Obg Management Logo Home
   
   
Free CME
Classifieds
Register/Login
Home Page Current Issue Past Issues Supplements Podcasts Information for Authors
                                    
   
About Us
Subscribe Renew
Reprints Permissions
Advertising Information
Links and Resources
Classifieds

Advertisement

September 2011 · Vol. 23, No. 9

Maternal asthma ups the risk of perinatal complications

Maternal asthma increases risk of preeclampsia, and affects baby’s size and timing of birth


Maternal asthma is associated with an increased risk of adverse perinatal outcomes, including increased risk of low birth weight, small for gestational age (SGA), preterm labor and delivery, and preeclampsia, according to a meta-analysis published online July 13 in BJOG: An International Journal of Obstetrics and Gynaecology.

Vaness E. Murphy, from the University of Newcastle and Hunter Medical Research Institute in Australia, and colleagues reviewed 103 articles (published between 1975 and 2009) reporting perinatal outcomes in pregnant women with and without asthma. Of these articles, 40 publications, involving 1,637,180 participants, were analyzed to ascertain whether maternal asthma is associated with an increased risk of adverse perinatal outcomes. Meta-analysis was performed with subgroup analyses by active asthma management and study design.

The investigators found that maternal asthma correlated with an increased risk of low birth weight (relative risk [RR], 1.46), SGA (RR, 1.22), preterm delivery (RR, 1.41), and preeclampsia (RR, 1.54). Active asthma management reduced the RR of preterm delivery (RR, 1.07), and preterm labor (RR, 0.96) to non-significant levels (RR, 1.07; 95 percent confidence interval [CI], 0.91 to 1.26 and RR, 0.96; 95 percent CI, 0.73 to 1.26, respectively).

"Pregnant women with asthma are at increased risk of perinatal complications, including preeclampsia and outcomes that affect the baby’s size and timing of birth," the authors write.

One of the study authors disclosed financial ties to the pharmaceutical industry.

We want to hear from you! Tell us what you think.

Back to top


Advertisement



ADVERTISEMENT   

ADVERTISEMENT   
ADVERTISEMENT   
Subscribe to our e-mail alert. We'll notify you of upcoming articles every month—and send you links to them before they are published.

Changing your e-mail address?
 
INSTANT POLL
What nonhormonal menopause interventions have you found to be effective?

ADVERTISEMENT